Prostate Cancer Awareness Month
September is Prostate Cancer Awareness month, and with the disease currently the second most common cancer in men worldwide, we wanted to provide relevant and pertinent information about this widespread condition.
Signs and Symptoms:
Early stage prostate cancer typically does not present any symptoms. More advanced stages sometimes show symptoms such as
- Trouble with urination or a slow or weak urinary stream
- Difficulty controlling bladder
- Frequent urges to urinate at night
- Blood in urine or semen
- Decrease in semen ejaculated
- Erectile dysfunction
- Pain in hips, spine, ribs, or other areas from cancer that has spread
- Swelling in legs or pelvic area
- About 1 in 9 men will be diagnosed with prostate cancer at some point in life.
- In 2018, there were 1.3 million new diagnoses of prostate cancer, representing 7.1% of all new cancer cases.
- There have been 358,989 deaths from prostate cancer so far in 2018, representing 3.8% of all cancer deaths.
- An estimated 2.3 million people will be diagnosed with prostate cancer in 2040.
- An estimated 730,000 people will die of prostate cancer in 2040.
- Prostate cancer is the second leading cause of cancer death in U.S. men.
- The average age of prostate cancer diagnosis is 66.
- The 5-year survival rate for local or regional prostate cancer is almost 100%.
- The 5-year survival rate for prostate cancer that has spread is 30%.
- The 10-year survival rate for local or regional prostate cancer is 98%.
Local or regional prostate cancer has a good survival rate, but prostate cancer that has spread does not have the same outlook. Early detection of the disease is important for survival, and for that, an accurate diagnosis is needed, along with recommendations for the best courses of treatment. As one of WorldCare’s covered conditions, a suspected diagnosis of prostate cancer is eligible for review by an expert team of medical specialists and sub-specialists at one of the leading hospitals of The WorldCare Consortium™. The hospitals of The WorldCare Consortium™ are consistently ranked among the best in the United States by U.S. News & World Report, and have access to over $4 billion in annual biomedical funding and consist of over 20,000 specialists & sub-specialists with access to the latest in medical innovation and discovery.